JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD

JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD B.Pharmacy IV Year PHARMACEUTICAL REGULATORY SCIENCE Previous Question Paper (June/July - 2024 - R17)

B.Pharmacy | IV Year | I | R17 | June/July - 2024

Answer PaperPaper Code: 247AFMaximum Marks: 75Time: 3 Hours

Note: i) Question paper consists of Part A, Part B.
ii) Part A is compulsory, which carries 25 marks. In Part A, answer all questions.
iii) In Part B, Answer any one question from each unit. Each question carries 10 marks and may have a, b as sub questions.

Part A

125 marks
a

Write down the difference between innovator and generics.

2 marks

Answer

An innovator drug is a new chemical entity protected by a patent, developed after extensive research and clinical trials. A generic drug is a pharmaceutical product designed to be bioequivalent to the innovator drug in dosage, strength, route of administration, and quality, usually marketed after the innovator's patent expires.

b

Write a note on IRB.

3 marks

Answer

An Institutional Review Board (IRB), also known as an Independent Ethics Committee, is an independent body consisting of medical, scientific, and non-scientific members. Its primary responsibility is to protect the rights, safety, and well-being of human subjects participating in clinical trials by reviewing and approving study protocols, informed consent documents, and investigator qualifications before the trial begins.

c

What are pre-clinical studies?

2 marks

Answer

Sign in to view the complete answer paper.

d

What is ACTD?

3 marks

Answer

Sign in to view the complete answer paper.

e

What are the advantages of ACTD?

2 marks

Answer

Sign in to view the complete answer paper.

f

Write about the safety monitoring of medical products.

3 marks

Answer

Sign in to view the complete answer paper.

g

What is the importance of investigator’s brochure?

2 marks

Answer

Sign in to view the complete answer paper.

h

Write about the approaches of 21 CFR part 11.

3 marks

Answer

Sign in to view the complete answer paper.

i

What is informed consent process?

2 marks

Answer

Sign in to view the complete answer paper.

j

What are clinical trials?

3 marks

Answer

Sign in to view the complete answer paper.

Part B

2

Define new drug according to FDA. Explain in detail the new drug development process with the time course for each phase.

10 marks

Answer

Sign in to view the complete answer paper.

OR
3

Explain different stages of drug discovery.

10 marks

Answer

Sign in to view the complete answer paper.

4

Explain the organization and functions of Australia and US drug regulatory bodies.

10 marks

Answer

Sign in to view the complete answer paper.

OR
5

Explain the application and regulatory approval process for IND.

10 marks

Answer

Sign in to view the complete answer paper.

6

What are open and closed part of DMF. Explain in detail on DMF system in India.

10 marks

Answer

Sign in to view the complete answer paper.

OR
7

What is Common Technical Document? Describe various CTD modules.

10 marks

Answer

Sign in to view the complete answer paper.

8

Discuss different stages of clinical studies.

10 marks

Answer

Sign in to view the complete answer paper.

OR
9

How can be clinical trials managed and monitored. Explain the development of clinical trial protocols.

10 marks

Answer

Sign in to view the complete answer paper.

10

Explain the code of federal regulation. Write a note on federal register.

10 marks

Answer

Sign in to view the complete answer paper.

OR
11

Explain in detail about orange book and purple book.

10 marks

Answer

Sign in to view the complete answer paper.

About this paper

This page contains the question paper of PHARMACEUTICAL REGULATORY SCIENCE from JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD for B.Pharmacy IV Year I, June/July - 2024, R17.

For the solved question paper with answers, switch to the Answer Paper tab.

Other papers in PHARMACEUTICAL REGULATORY SCIENCE

Loading Question Papers

Fetching data from database...